Esclerosis múltiple y calidad de vida

Revista de Neurologia

Volumn 24, Issue 134, 1996, Pages 1221-1223

  Hernandez M A ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; HUMAN; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW;

BRAIN; HUMANS; MULTIPLE SCLEROSIS; QUALITY OF LIFE;

EID: 0030255698     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Weinshenker BG, Bass B, Rice GP, et al. The natural history in multiple sclerosis: a geographically based study. Clinical course and disability. Brain 1989; 112: 133-146.
2. Godin DS. The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review. Neurology 1991; 41: 980-985.
3. Gill TM, Feinstein R. A critical appraissal of the quality of life measurements. JAMA 1994; 272: 619-626.
4. Feld R. Endpoints in cancer clinical trials: is there a need for mesauring quality of life? Support Care Cancer 1995; 3: 23-27.
5. Cella D. Methods and problems in measuring quality of life. Support Care Cancer 1995; 3: 11-22.